Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 170
Selected: 0
NCT IDTitle
NCT01510119Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
NCT00770055Internet Use Among Women With Recurrent Metastatic Breast Cancer
NCT00578240Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT04585269Bright IDEAS - Young Adults Problem-Solving Skills Training
NCT05373823MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
NCT02315196Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
NCT01006369Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT00176488Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
NCT02699983eHealth Weight Loss Program in African American Breast Cancer Survivors
NCT00962845Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT04075734Feasibility of a Self-Management + Peer Mentoring Intervention for Adolescent and Young Adult Childhood Cancer Survivors
NCT00895115Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer
NCT00667901Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
NCT00608972Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
NCT00161187Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
NCT05785780Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT01617161Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT00138151Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
NCT00176501Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
NCT01407562Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
NCT02458716Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer
NCT00295932Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
NCT00634634Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
NCT04929015Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
NCT00176462CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
NCT00749437Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
NCT01828476Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer
NCT05400941Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care
NCT02620527Concordance Between ctDNA Assay and FoundationOne
NCT00996359Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
NCT00385398QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC
NCT02748564Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
NCT00251186First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
NCT00943709Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
NCT01220973Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
NCT01652014Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
NCT00899808Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer
NCT03725449Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
NCT02526498Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
NCT00118066Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
NCT00966667Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
NCT01711944Online Problem Solving Skills Training
NCT03272633Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
NCT00176527Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT06927700Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
NCT03108911Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
NCT01018836Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
NCT02177838Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
NCT01326286Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer
NCT00786682Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer